A prespecified analysis of the MASTER DAPT trial has confirmed that the absence of ischemic risk and reduction in bleeding with abbreviated dual antiplatelet therapy (DAPT) in patients at high bleeding risk undergoing intervention ...
Aug 29, 2022
0
9
A novel artificial intelligence (AI) algorithm uses routine echocardiograms to identify aortic stenosis patients at high risk of death who could benefit from treatment. The late breaking research was presented in a Hot Line ...
Aug 29, 2022
0
4
Atrial fibrillation screening using conventional smartphones more than doubles the detection and treatment rate in older people compared to routine screening, according to late breaking research presented in a Hot Line session ...
Aug 29, 2022
0
4
A randomized trial in more than 45,000 men has suggested that cardiovascular screening including cardiac imaging, blood pressure measurement and blood tests, plus treatment if needed, may lower the risk of death, heart attack ...
Aug 29, 2022
0
5
Two myocardial perfusion imaging (MPI) tests for selecting patients with suspected coronary artery disease (CAD) for invasive testing have high specificity but low sensitivity in patients who have undergone coronary computed ...
Aug 29, 2022
0
6
Selection of non-infarct related artery (IRA) lesions for intervention using fractional flow reserve (FFR) is superior to routine angiography-based selection in patients with acute myocardial infarction and multivessel disease. ...
Aug 29, 2022
0
15
A novel artificial intelligence (AI) algorithm accurately estimates the risk of heart disease caused by cumulative exposure to cholesterol and blood pressure levels and the benefits of lowering both—thus providing the essential ...
Aug 29, 2022
0
8
In patients with advanced chronic kidney disease and chronic coronary disease, an invasive strategy does not reduce the five-year risk of death compared to a conservative strategy. That's the finding of late breaking research ...
Aug 29, 2022
0
27
Long-term low-density lipoprotein (LDL) cholesterol lowering with evolocumab is safe and well tolerated and leads to further reductions in cardiovascular events compared with shorter treatment, according to late breaking ...
Aug 29, 2022
0
7
Sacubitril/valsartan is superior to ramipril in high-risk survivors of acute myocardial infarction, according to a post hoc win ratio analysis of the PARADISE-MI trial presented in a Hot Line session on 29 August at ESC Congress ...
Aug 29, 2022
0
54
